Trial Profile
A Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir (Tamiflu) in Patients in the Intensive Care Unit
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary) ; Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Pharmacokinetics
- 03 Apr 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 19 Feb 2009 New trial record